JB Chemicals acquires brand 'Azmarda' from Novartis

13 Apr 2022 Evaluate

JB Chemicals & Pharmaceuticals has successfully completed the acquisition of the brand 'Azmarda' from Novartis AG, Switzerland. Azmarda indicated for heart failure patients with reduced ejection fraction (HfrEF).

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

2155.45 70.35 (3.37%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×